The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
101686392 10168639 2 F 20160719 20140513 20160719 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-20704490 BRISTOL MYERS SQUIBB 0.00 Y 0.00000 20160719 CN US FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
101686392 10168639 1 PS EFAVIRENZ EFAVIRENZ 1 Unknown U 20972

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
101686392 10168639 1 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
101686392 10168639 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
101686392 10168639 Cerebral ventricle dilatation
101686392 10168639 Foetal exposure during pregnancy
101686392 10168639 White matter lesion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found